Blisovi Fe 1.5/30 Kit
Product Images NDC 68180-866

11 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Blisovi Fe 1.5/30 (NDC 68180-866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Norethindrone Acetate Usp (C24ab27d 7cee 4bd9 B741 3dd4194f3170 01)

Norethindrone Acetate Usp (C24ab27d 7cee 4bd9 B741 3dd4194f3170 01)
Chemical structure of norethindrone acetate, showing its molecular formula C22H28O3 and molecular weight 340.46.*
FDA Label Image

Ethinyl Estradiol Usp (C24ab27d 7cee 4bd9 B741 3dd4194f3170 02)

Ethinyl Estradiol Usp (C24ab27d 7cee 4bd9 B741 3dd4194f3170 02)
Chemical structure of Ethinyl Estradiol, showing its molecular formula C20H24O2 and molecular weight of 296.40.*
FDA Label Image

Table Ii (C24ab27d 7cee 4bd9 B741 3dd4194f3170 03)

Table Ii (C24ab27d 7cee 4bd9 B741 3dd4194f3170 03)
A bar chart presenting circulatory disease mortality rates per 100,000 woman years by age group, smoking status, and oral contraceptive use. The chart compares mortality rates across four categories: ever-users (non-smokers and smokers) and controls (non-smokers and smokers) for age groups 15-24, 25-34, 35-44, and 45 and older.*
FDA Label Image

Figure 1: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (C24ab27d 7cee 4bd9 B741 3dd4194f3170 04)

Figure 1: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (C24ab27d 7cee 4bd9 B741 3dd4194f3170 04)
A forest plot showing effect estimates (OR, RR, HR) with confidence intervals from various studies comparing 'Ever COC vs. Never COC Use' and 'Current COC vs. Never-Use'. The x-axis represents effect estimate values from -1.50 to 2.00, with a reference line at 1.00. The plot includes studies from NICHD, French E3N, Shanghai Women's Health, Nurses' Health, Oxford Family Planning, and Danish Sex Hormone Register, displaying relative risk, odds ratio, and hazard ratio data.*
FDA Label Image

Image (C24ab27d 7cee 4bd9 B741 3dd4194f3170 05)

FDA Label Image

Day 1 Starter: If Your Period Begins On A Day Other Than Sunday, Place The Day Label Strip That Starts With First Day Of Your Period. (C24ab27d 7cee 4bd9 B741 3dd4194f3170 06)

Day 1 Starter: If Your Period Begins On A Day Other Than Sunday, Place The Day Label Strip That Starts With First Day Of Your Period. (C24ab27d 7cee 4bd9 B741 3dd4194f3170 06)
An instructional diagram for Blisovi Fe 1.5/30 pill pack showing a 4-week calendar layout to guide pill intake. Days are labeled Sunday through Saturday, with arrows indicating pill consumption from left to right each week. The diagram includes instructions for starting on Sunday or the first day of the menstrual period, highlighting the designated starting point.*
FDA Label Image

Day 1 Starter: If Your Period Begins On A Day Other Than Sunday, Place The Day Label Strip That Starts With First Day Of Your Period. (C24ab27d 7cee 4bd9 B741 3dd4194f3170 07)

Day 1 Starter: If Your Period Begins On A Day Other Than Sunday, Place The Day Label Strip That Starts With First Day Of Your Period. (C24ab27d 7cee 4bd9 B741 3dd4194f3170 07)
An instructional diagram for Blisovi Fe 1.5/30 pill pack showing a weekly pill schedule divided into four rows labeled Week 1 to Week 4. Each row has circular pill indicators arranged from Sunday to Saturday. Arrows indicate the direction to take pills from left to right each week. Additional text guides Day-1 starters to place the day label strip according to their period day and instructs both Sunday and Day-1 starters on where to begin taking pills.*
FDA Label Image

Image (C24ab27d 7cee 4bd9 B741 3dd4194f3170 08)

FDA Label Image

Image (C24ab27d 7cee 4bd9 B741 3dd4194f3170 09)

Image (C24ab27d 7cee 4bd9 B741 3dd4194f3170 09)
Blisovi Fe 1.5/30 foil packaging label containing norethindrone acetate and ethinyl estradiol tablets USP with ferrous fumarate tablets. The label shows the product name, strengths (1.5 mg/0.03 mg), storage instructions, manufacturer Lupin Limited (India), and distributor Lupin Pharmaceuticals, Inc. (Naples, FL). The package includes a calendar dosing guide for daily tablet intake by week and day of the week.*
FDA Label Image

Image (C24ab27d 7cee 4bd9 B741 3dd4194f3170 10)

Image (C24ab27d 7cee 4bd9 B741 3dd4194f3170 10)
Label for Blisovi Fe 1.5/30 tablets by Lupin Pharmaceuticals, Inc. The label specifies norethindrone acetate 1.5 mg and ethinyl estradiol 0.03 mg tablets with ferrous fumarate tablets included. Packaging indicates a blister pack of 28 tablets, with detailed dosing and prescription information, featuring Lupin's logo and contact details.*
FDA Label Image

Image (C24ab27d 7cee 4bd9 B741 3dd4194f3170 11)

Image (C24ab27d 7cee 4bd9 B741 3dd4194f3170 11)
Packaging label for Blisovi Fe 1.5/30 tablets by Lupin Pharmaceuticals, Inc. The label lists active ingredients norethindrone acetate 1.5 mg and ethinyl estradiol 0.03 mg, along with ferrous fumarate tablets. It includes product NDC 68180-866-73 and states the package contains 3 blisters of 28 tablets each. The label features dosage, manufacturer/distributor information, and warnings about contraceptive use and disease prevention.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.